A detailed history of U.S. Capital Wealth Advisors, LLC transactions in Ishares Tr Genomics Immunology stock. As of the latest transaction made, U.S. Capital Wealth Advisors, LLC holds 23,427 shares of IDNA stock, worth $611,678. This represents 0.02% of its overall portfolio holdings.

Number of Shares
23,427
Previous 29,714 21.16%
Holding current value
$611,678
Previous $609,000 9.2%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 09, 2025

SELL
$20.64 - $23.61 $129,763 - $148,436
-6,287 Reduced 21.16%
23,427 $553,000
Q2 2025

Jul 14, 2025

BUY
$17.92 - $21.5 $81,571 - $97,868
4,552 Added 18.09%
29,714 $609,000
Q1 2025

Apr 29, 2025

BUY
$20.49 - $23.63 $124,025 - $143,032
6,053 Added 31.68%
25,162 $515,000
Q4 2024

Jan 24, 2025

BUY
$22.38 - $25.53 $427,659 - $487,852
19,109 New
19,109 $432,000

Others Institutions Holding IDNA

About ISHARES TR GENOMICS IMMUNOLOGY


  • Ticker IDNA
  • Sector ETFs
  • Industry ETFs
More about IDNA
Track This Portfolio

Track U.S. Capital Wealth Advisors, LLC Portfolio

Follow U.S. Capital Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of U.S. Capital Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on U.S. Capital Wealth Advisors, LLC with notifications on news.